Review topic: A detailed analysis of transdermal drug delivery system

Transdermal drug delivery systems (TDDS) are a novel approach for administering medications through the skin, offering several advantages over conventional methods like oral or intravenous delivery. TDDS allow for controlled and consistent drug release, effectively bypassing the gastrointestinal tract and avoiding first-pass metabolism, which can enhance bioavailability and reduce systemic side effects. However, the skin's barrier properties present significant challenges for drug permeation, particularly for larger or hydrophilic molecules. To address these challenges, various methods have been developed, including chemical permeation enhancers, microneedles, iontophoresis, and sonophoresis, to facilitate drug delivery.
The typical components of TDDS include an active pharmaceutical ingredient, an adhesive matrix, a release liner, and a backing layer, each contributing to the controlled release and stability of the system. Despite these advancements, TDDS are primarily effective for small, lipophilic drugs, and issues such as skin irritation and limited permeation for larger molecules continue to be significant challenges. Recent innovations, such as the use of nanoparticles, 3D printing technology, and personalized delivery systems, show promise in overcoming these limitations. This review examines the principles, benefits, challenges, and recent developments in transdermal drug delivery systems, highlighting their potential applications in chronic disease management, hormone therapy, and vaccine delivery, as well as future directions for enhancing their efficacy and expanding their therapeutic range.